Skip to content

2024 MIPS Measure #290: Assessment of Mood Disorders and Psychosis for Patients with Parkinson’s Disease



MIPS Clinical Quality Measures (CQMS)



Percentage of all patients with a diagnosis of Parkinson’s disease (PD) who were assessed for depression, anxiety, apathy, AND psychosis once during the measurement period.


This measure is to be submitted a minimum of once per performance period for patients with a diagnosis of Parkinson’s disease seen during the performance period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding.

NOTE: Patient encounters for this measure conducted via telehealth (including but not limited to encounters coded with GQ, GT, 95, POS 02, POS 10) are allowable.

‌Measure Submission Type

Measure data may be submitted by individual MIPS eligible clinicians, groups, or third-party intermediaries. The listed denominator criteria are used to identify the intended patient population. The numerator options included in this specification are used to submit the quality actions as allowed by the measure. The quality data codes listed do not need to be submitted by MIPS eligible clinicians, groups, or third-party intermediaries that utilize this modality for submissions; however, these codes may be submitted for those third-party intermediaries that utilize Medicare Part B claims data. For more information regarding Application Programming Interface (API), please refer to the Quality Payment Program (QPP) website.


All patients with a diagnosis of Parkinson’s disease

DENOMINATOR NOTE: *Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician Fee Schedule (PFS). These non-covered services should be counted in the denominator population for MIPS CQMs.

Denominator Criteria (Eligible Cases):

All patients regardless of age


Diagnosis for Parkinson’s disease (ICD-10-CM): G20.A1, G20.A2, G20.B1, G20.B2, G20.C


Patient encounter during the performance period (CPT): 99202, 99203, 99204, 99205, 99211, 99212, 99213, 99214, 99215, 99242*, 99243*, 99244*, 99245*, 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99421, 99422, 99423, 99441, 99442, 99443, 99483


Patients who were assessed for depression, anxiety, apathy, AND psychosis once during the measurement period


Assessed use of a screening tool or discussion with the patient or care partner. Please see “Opportunity for Improvement” section below for suggestions on possible screening tools.

Psychosis includes hallucinations, illusions, delusions, paranoia.

Numerator Instructions:

The following screening tools may be helpful for use in practice:

  • For depression:
    • Geriatric Depression scale Beck Depression
    • Hamilton Depression scale
    • Patient Health Questionnaire 2 (PHQ2)
    • Patient Health Questionnaire 9 (PHQ9)
    • Montgomery-Asberg Depression Rating Scale (MADRS)
  • For Anxiety:
    • Beck Anxiety Inventory
    • Hospital Anxiety and Depression Scale Self-rating Anxiety Scale
    • Anxiety Status Inventory Strait Trait Anxiety Inventory
    • Hamilton Anxiety Rating Scale
    • Parkinson Anxiety Scale (PAS)
  • For Psychosis:
    • Parkinson psychosis rating scale
    • Rush hallucination inventory
    • Baylor hallucination questionnaire
    • Neuropsychiatric inventory (NPI or NPI-Q)
    • Brief psychiatric rating scale
    • Positive and negative syndrome scale
    • Schedule for assessment of positive symptoms
    • Unified Parkinson disease rating scale Part I

Numerator Options:

Performance Met: Depression, anxiety, apathy, AND psychosis assessed (G2121)


Performance Not Met: Depression, anxiety, apathy, AND psychosis not assessed (G2122)

Stay updated with the latest news regarding MACRA and MIPS

The Healthmonix Advisor is a free news source that connects you to the latest in the value-based care industry!

Ready to report like a pro?

See how